Directors

Dr Paul Tan, Chief Executive Officer

Dr Paul Tan has been an executive director since 23 February 2007 and was appointed as Chief Executive Officer of the Group on 23 December 2008. Paul joined the company in 2004 as the Managing Director of LCT's New Zealand operations.

Prior to this he was Chief Executive Officer of CenTec Ltd and founding Deputy Director and Head of Health Division at Genesis Research & Development Corporation Limited. He has wide experience in all aspects of assessment and selection of products for commercialisation, expansion of intellectual property, product development and managing critical paths, timelines and establishing and managing international partnerships. He has been a research fellow, associate professor in immunology and a physician rheumatologist. He is on the NZBio National Advisory Council and Committee of the NZBio Auckland.

Emeritus Professor Robert Elliott, Medical Director

Professor Elliott trained as a Paediatrician at Adelaide University. He moved to New Zealand in 1970 to become the Foundation Professor, Director of Paediatrics at the University of Auckland. Professor Elliott co-founded LCT. He is an Emeritus Professor of Child Health Research, Professor of Paediatrics and a world leader in diabetes and autoimmune related research.

He is on the board of the New Zealand Child Health Foundation, Wings Trust (a NZ trust for the treatment of alcohol and substance abuse) and patron of the NZ Cystic Fibrosis Foundation. In 1999 he was awarded a CNZM (a Companion of the New Zealand Order of Merit) for services to the community.

Mr David Brookes, Independent Director and Chairman

Dr Brookes has a Bachelor of Medicine and Bachelor of Surgery from Adelaide University and is a Fellow of the Australian College of Rural and Remote Medicine.

He currently works as a general medical practitioner and has extensive experience in rural Australia, especially in paediatric and procedural practice. His involvement in the biotechnology sector started in the mid 1990's, as an analyst for broking firm Taylor Collison Ltd. He is also currently Chairman of Innovance Ltd (listed on the Newcastle stock exchange) and a director of Atcor Medical Holdings Ltd, listed on the ASX. He was elected Chairman on 23 September 2009.

Simon O'Loughlin, Independent Director

Simon O'Loughlin is a legal practitioner with over 25 years experience as a corporate and commercial solicitor. He has had extensive involvement in the corporate world, especially in relation to the formation, structuring and listing of small to medium sized companies. Simon is Chairman of WCP Resources Ltd and Bondi Mining Ltd, as well as a director Aura Energy Ltd, Petratherm Ltd, Chesser Resources Ltd and Probionics Ltd. Simon's knowledge of Australian Corporate Law and ASX listing rules is critical for his role on the board and its committees.

Mr Laurie Hunter, Independent Director

Laurie has over 35 years experience as a stockbroker, investment banker and corporate investor in London, Paris and San Francisco. Laurie was aMember of The Stock Exchange, London, a partner at L. Messel and Co, London, a director of Shearson Lehman Hutton and founder of Hunter Capital.

His recent focus has been on investing and providing strategic advice to developing companies.

Bob Finder, Independent Director

Mr Finder has over 35 years experience in the international biotech/pharmaceutical and chemical industries. He is Chairman of the Board of the ASX-listed LabTech System (LBT) and a Director on the Board of National Pharmacies. Bob was Managing Director and Chief Executive Officer of GroPep, and subsequently CEO of Novozymes GroPep Limited, the Australian subsidiary of Novozymes, a global biotechnology company. Prior to joining GroPep in 2002, he was President and Chief Operating Officer of Mayne Pharma responsible for the commercial activities for the Americas and Asia Pacific region as well as for global research and Faulding Pharmaceuticals - Asia Pacific. He is a Member of the Australian Institute of Company Directors and of the American Institute of Chemical Engineers and has a Bachelor of Science Chemical Engineering from the University of Detroit. He was appointed to the board on 23 September 2009.

David McAuliffe, Independent Director

Mr McAuliffe has over 14 years experience in the international Life Science sector. During this time he has been involved in numerous capital raisings and technology in-licensing exercises. He is the founder of NeuroDiscovery and has been a Director since establishment. He founded several biotechnology companies in Australia, France and the United Kingdom, many of which have become public companies. David has an Honours Degree in Law and a Bachelor of Pharmacy degree and is President of the Dyslexia - Speld Foundation WA (Inc). He was appointed to the board on 23 September 2009.

Nick Geddes, Company Secretary

Nick is the principal of Australian Company Secretaries, a company secretarial practice, which he formed in 1993. He is a member of the National Council of Chartered Secretaries Australia and Chairmanof the NSW Branch of that Institute, with previous experience as a Chartered Accountant and Company Secretary, including investment banking and development and venture capital in Europe, Africa, the Middle East and Asia.